QT
Quantbot Technologies Portfolio holdings
AUM
$3.9B
1-Year Return
6.06%
This Quarter Return
-1.5%
1 Year Return
+6.06%
3 Year Return
+15.52%
5 Year Return
+20.93%
10 Year Return
+4.18%
AUM
$2.74B
AUM Growth
+$202M
(+8%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
8.47%
Top 10 Holdings %
Top 10 Hldgs %
7.11%
Holding
1,929
New
529
Increased
484
Reduced
411
Closed
505
Top Buys
| 1 |
Intel
INTC
|
+$24M |
| 2 |
General Dynamics
GD
|
+$15.9M |
| 3 |
Lockheed Martin
LMT
|
+$15.9M |
| 4 |
Rubrik
RBRK
|
+$15.4M |
| 5 |
Lam Research
LRCX
|
+$15.1M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$22.8M |
| 2 |
Chevron
CVX
|
+$18.2M |
| 3 |
Amphenol
APH
|
+$17.2M |
| 4 |
Bank of America
BAC
|
+$14.7M |
| 5 |
Edwards Lifesciences
EW
|
+$13.6M |
Sector Composition
| 1 | Technology | 19.6% |
| 2 | Industrials | 15.35% |
| 3 | Financials | 15.31% |
| 4 | Consumer Discretionary | 15.05% |
| 5 | Healthcare | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Recursion Pharmaceuticals
RXRX
$1.98B
| $2.72K | ﹤0.01% |
+403
| New | +$2.72K |
|
1402
Zumiez
ZUMZ
$356M
| $2.72K | ﹤0.01% |
+142
| New | +$2.72K |
|
1403
Washington Trust Bancorp
WASH
$570M
| $1.94K | ﹤0.01% |
+62
| New | +$1.94K |
|
1404
argenx
ARGX
$46.7B
| $1.85K | ﹤0.01% |
+3
| New | +$1.85K |
|
|
SUPV
1405
Grupo Supervielle
SUPV
$548M
| $1.74K | ﹤0.01% |
115
-28,692
| -100% | -$434K |
|
1406
J. Jill
JILL
$268M
| $1.33K | ﹤0.01% |
+48
| New | +$1.33K |
|
1407
Central Garden & Pet
CENT
$2.28B
| $698 | ﹤0.01% |
+18
| New | +$698 |
|
1408
Arrowhead Research
ARWR
$3.99B
| $696 | ﹤0.01% |
37
-7,669
| -100% | -$144K |
|
|
BLTE
1409
Belite Bio
BLTE
$2.18B
| $694 | ﹤0.01% |
+11
| New | +$694 |
|
1410
Ultragenyx Pharmaceutical
RARE
$3.02B
| $673 | ﹤0.01% |
+16
| New | +$673 |
|
|
GRAL
1411
GRAIL, Inc. Common Stock
GRAL
$1.28B
| $625 | ﹤0.01% |
+35
| New | +$625 |
|
1412
Astronics
ATRO
$1.55B
| $447 | ﹤0.01% |
+28
| New | +$447 |
|
1413
Altimmune
ALT
$324M
| $433 | ﹤0.01% |
+60
| New | +$433 |
|
1414
Soleno Therapeutics
SLNO
$3.19B
| $405 | ﹤0.01% |
9
-235
| -96% | -$10.6K |
|
1415
Twist Bioscience
TWST
$1.46B
| $372 | ﹤0.01% |
+8
| New | +$372 |
|
1416
IAMGOLD
IAG
$6.27B
| $325 | ﹤0.01% |
+63
| New | +$325 |
|
1417
Disc Medicine
IRON
$2.08B
| $254 | ﹤0.01% |
4
-2,960
| -100% | -$188K |
|
1418
CG Oncology
CGON
$2.56B
| $201 | ﹤0.01% |
+7
| New | +$201 |
|
1419
Schrodinger
SDGR
$1.34B
| $96 | ﹤0.01% |
5
-13,596
| -100% | -$261K |
|
1420
Arcellx
ACLX
$4.03B
| $77 | ﹤0.01% |
+1
| New | +$77 |
|
1421
Burke & Herbert Financial Services Corp
BHRB
$932M
| $62 | ﹤0.01% |
1
-1,933
| -100% | -$120K |
|
1422
Janux Therapeutics
JANX
$1.46B
| $54 | ﹤0.01% |
1
-65
| -98% | -$3.51K |
|
1423
Sana Biotechnology
SANA
$749M
| $54 | ﹤0.01% |
33
-170
| -84% | -$278 |
|
1424
Cabaletta Bio
CABA
$159M
| $43 | ﹤0.01% |
+19
| New | +$43 |
|
1425
Supernus Pharmaceuticals
SUPN
$2.59B
| – | – |
-1,026
| Closed | -$32K |
|